Navigation Links
DuPont Provides Technology for Washington Hospital Center's Emergency Department
Date:1/10/2008

DuPont Products Help Address Infection Control

WASHINGTON, Jan. 10 /PRNewswire-FirstCall/ -- To help address infection control during everyday hospital operations and minimize risks during times of health crisis, DuPont (NYSE: DD) today announced that one of its healthcare products, DuPont(TM) Corian(R) solid surface, has been selected by the Washington Hospital Center for its emergency department. The product recently was incorporated into a children's ward at the Roswell Park Cancer Institute in Buffalo, N.Y.

Washington Hospital Center is using the technology as part of its vision to build ER One, which will be an all-risks-ready emergency care facility, created to provide emergency medical care during acts of terrorism and emerging illness and built to function fully as a hospital emergency department during daily operations. The current phase of the project, entitled "Bridge to ER One," will test these new innovations and technologies.

"Our DuPont innovations are designed to provide solutions that protect lives," said Thomas F. Schuler, vice president and general manager -- DuPont Building Innovations. "Corian(R) is one of our products that uniquely meets both the stringent safety specifications of the healthcare industry as well as the aesthetic demands of healthcare designers."

The 2006 Guidelines for Design and Construction of Hospital and Healthcare Facilities has defined the 18 preferred characteristics of the ideal healthcare surface to help facilitate improved infection control. Corian(R) meets all 18 of these characteristics, including being nonporous, seamless, durable and not supporting microbial growth when cleaned properly.

"Corian(R) was selected for the Bridge to ER One because
'/>"/>

SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
2. ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke
3. Progen Provides Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
4. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
5. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
6. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
7. Replidyne Provides Strategic Update
8. BioCryst Provides Forodesine HCl Update
9. Celtic Pharma Provides Update on XERECEPT(R) Clinical Program
10. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
11. Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...om Multiple Cancer Populations Facilitates ...ich., Oct. 13 /- Rubicon Genomics, In...k to amplify DNA samples for The,Cancer Atlas Geno...lify and standardize total genomic,DNA from 3,000 ... Rubicon,GenomePlex(TM) Whole Genome Amplification...
(Date:10/12/2008)... thin struts designed for more uniform drug ... and WASHINGTON, Oct. 12 /-... announced comprehensive data from,the TAXUS ATLAS...,multi-center, single-arm, historically controlle...aclitaxel-Eluting Stent System in a variety of,les...
(Date:10/10/2008)...10 /- Diplomat Specialty,Pharmacy ann...iplomat,Specialty Pharmacy to be one of only three...herapy Optimization Study for Multiple Sclerosis (... is to examine the benefits of a,specialty pharmac...nce and,patient outcomes. Targeted patient outcome...
(Date:10/10/2008)...Newswire-FirstCall/ -- Boston Scientific,Corporati...he Company,s major,events and press announcements ...twentieth annual Transcatheter Cardiovascular Ther...om October 12 to 17 in Washington, D.C., Boston S...y and,efficacy data on its TAXUS(R) Express2(TM) a...
Breaking Medicine Technology:Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 2Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 5Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 6Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6Team finds an economical way to boost the vitamin A content of maize 1947 1Team finds an economical way to boost the vitamin A content of maize 1947 2Team finds an economical way to boost the vitamin A content of maize 1947 3Fleishman Hillard Names FFI Global Cause for 2008 9741 1Fleishman Hillard Names FFI Global Cause for 2008 9741 2Immune Therapy May Help Some Heart Failure Patients 9737 1Immune Therapy May Help Some Heart Failure Patients 9737 2Immune Therapy May Help Some Heart Failure Patients 9737 3Report Urges More Research Into Cell Phones 9734 1Report Urges More Research Into Cell Phones 9734 2Report Urges More Research Into Cell Phones 9734 3
...-FirstCall/ --,Pharmacyclics, Inc. announced today...e deacetylase (HDAC) inhibitor and,Bruton,s tyrosi...ill take place at the American Association for Can... April 14-18, 2007, at the Los,Angeles Convention ...ns are as follows:, Sunday, April 15, 2007, ...
...ence in Barcelona,Spain, VANCOUVER and SAN DIEGO,...IX Inc. , a clinical-stage developer,of drugs for ...ults,confirming the previously announced clinical ...clinical benefit, safety and,tolerability in a Pha...itor, celgosivir (MX-3253), in combination with pe...
Other Medicine Technology:Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 2Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 3Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 4New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 2New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 3New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 4New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 5New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 6New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 7New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 8
(Date:10/13/2008)...eading Content Rights Management System, Supports... Content Spend, WEST CHESTER, Pa., Oct. 13 /PRNew...ding global pharmaceutical manufacturer has integr...primary platform for the,secure distribution, data...cs for their new product video content. Imperium i...
(Date:10/13/2008)...swire/ -- The National Coalition for,Quality Color...ncerns over,the National CT Colonography Study pub...Medicine. The evidence must be closely evaluated, ...y is not without significant,potential risks. The ...py,remains the "Gold Standard" for colorectal canc...
(Date:10/13/2008)...blem in daily life, survey shows, PORTLAND, Ore.,...three-quarters of people living with psoriasis say...e, according to a National Psoriasis,Foundation 20...viduals with psoriasis and psoriatic arthritis,als...ly lives, shapes their,feelings about themselves a...
(Date:10/13/2008)...swire/ -- During the Pri-Med New York,conference a...are providers,took a 20-question quiz prepared by ...n Somerset, NJ. The quiz tested basic knowledge of..., EMR software, and healthcare,administration., T... The average number,of correct answers was only 7....
Breaking Medicine News(10 mins):Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:National Psoriasis Foundation Releases 2008 Study Results 2Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2
... in helping us grow from a hollow sphere of stem c... They found that in the first few days of life, ce...ive ectoderm from which embryonic tissues develop,... biochemist at the Medical College of Georgia. Pr...
...riott International claimed the complete elimina...nu throughout all its 2300// hotels. The company ...ar and had since phased out trans-fats; partially ...rteries, from its cookies, breads, salad dressings...
...ore dispensaries by 2010 to provide better healthc... said Thursday.// She said 365 dispensaries were ... would be set up soon to "enable the common men av...heir doorsteps". The chief minister said her gov...
...ce and cherries, plus drinking red wine daily coul..., says a new study.// Scientists have found melato... from age-related damage, said the online edition ...s a naturally-occurring hormone not only found in ...
Other Medicine News:Health News:Lipid Plays Big Role in Embryonic Development 2
The standard pH Testing Application for POLYGRAM NET® (PNET) works with the Bravo™ Catheter-Free pH Monitoring System, Digitrapper™ Catheter-Based pH Recorder, and the Synectics Digit
...The Esophageal Manometry Application for POLYGRAM ...multiparametric recorder to record and analyze pre...uring esophageal manometry procedures. The PNET so...e solid-state or water-perfused manometry catheter...
The Biofeedback Application for POLYGRAM NET™ (PNET) works with the Polygraf™ ID to display, record, and analyze pressure and EMG signals from the pelvic floor in an interactive graphic f
...The Bile Reflux Analysis for POLYGRAM NET® is ...This add-on allows medical professionals to upload... ambulatory bile reflux recorder. The primary diff...sorbance of a certain wavelength of light correspo...
Medicine Products: